Did you know hybrid measures aren't new? In 2018, Medisolv participated in CMS’s hybrid readmission measure pilot program and as a part of that pilot, we submitted hybrid data electronically for hospitals that we support. There were only 150 submissions nationwide and our clients accounted for 69 of them. Even before that, Medisolv worked with the Yale Center for Outcomes Research and Evaluation (CORE) and CMS to test the feasibility of the hybrid readmission measure. Fast forward to 2022 and we've made it through testing, pilot submissions, a new measure rollout, and we’ve just concluded voluntary submission of the hybrid readmission measure.
Here's what we learned by submitting the hybrid measure data this year and here's some information on each hybrid measure so you can prepare your organization for these new measures and requirements.
There are currently two hybrid measures that are part of your IQR program requirements. The Hybrid Hospital-Wide Readmission measure (CMS 529) and the Hybrid Hospital-Wide Risk-Standardized Mortality measure (CMS 844).
Both measures are required starting with the 2023 reporting period. The good news is that there is one more voluntary reporting period for your organization to participate in. The voluntary reporting period allows you to review your processes, implement data collection, and “practice” submission before the measures are mandatory and publicly reported. This practice time is critical to improvement and success.
You may be thinking that it isn’t worth spending time submitting hybrid measure data during the voluntary reporting years, after all, you probably feel pretty comfortable with eCQMs by this point. If hybrid measures were “normal” eCQMs, we might agree with you, but hybrid measures are different than eCQMs and actually aren’t eCQMs at all! So here at Medisolv we are glad we did these submissions for our clients again. We’ve learned a lot over the last few months and expect to learn even more once the Hospital Specific Reports (HSRs) are published next spring.
Just as you need to start working on collecting data for these measures now, you also need to start planning for the submission process now. Even as you are first implementing the measures, well in advance of the submission window, we suggest you analyze the QRDA I files. Confirm that the schema is correct and that there aren’t any obvious issues that will cause rejections and/or errors. Then you should go through that same process again just before the submission window opens. Nope, we aren’t kidding. Just as the data collected and workflow can change throughout the year, so can the QRDA I files.
You'll want to leave adequate time for submission. Complete a final data review and run test submissions before you submit. Here at Medisolv, we do multiple data reviews and test submissions before we even think about submitting to production. Start the submission testing as soon as CMS opens the submission window. Because you must submit eight separate files, four quarters for each measure, the submission process can take a long time, especially if there are errors and rejections that need to be reviewed and corrected. We had some files that needed to be submitted multiple times after errors were addressed.
We’ll let you in on a little secret…below is a list of the most common reasons for rejection and resubmission we saw this year. Keep these in mind and maybe you’ll save yourself some painful resubmissions:
Bottom line? Don’t expect submission to be as easy as an upload and a click of the mouse. Make sure you document the process and report any issues and suggestions to CMS via ONC Jira tickets. We also suggest you establish communication with measure stewards and use other resources.
Remember! If you have Medisolv we do all this for you. Our SubmissionsPlus® Assurance means we take care of all the moving parts of your submission on your behalf.
Yes. It was worth it.
It was also a pain in the you know what. It was voluntary so it was not a priority for many of our clients, but everyone understood the importance of participating. Hospitals learned about the measure, implemented processes, updated mapping and now have plans for validation and improvement throughout the reporting year. The Medisolv team learned a lot about the submission process, where we can enhance our applications to better support our clients and are better prepared for next year.
Will we do it again? Absolutely - and for both measures next year.
CMS has made it clear they are moving toward a fully digital measurement system. Hybrid measures are technically the first dQM since they are calculated using multiple health information sources.
These measures give us the opportunity to integrate clinical information into hospital quality measurement without manual chart abstraction.
For years, health leaders complained that the claims-only readmissions and mortality measures were not an accurate reflection of how sick their patients were upon entering their facilities. By incorporating clinical data, this provides a fairer picture of the patient's severity of illness.
If you are a client and want to participate in voluntary reporting of one or both measures (and you're not already actively participating) reach out to us. If you are looking for assistance with your hybrid and eCQM measure performance, please schedule a 1 on 1 call with us. We'd love to show you how we can help your organization get ready for this digital shift.
A hybrid measure is a combination of claims data (information submitted for a specific encounter) and EHR data (clinical data). CMS gathers your claims data through the normal process. CMS gets your EHR data through the hybrid measure submissions we just reviewed. CMS then combines the data from each, performs a risk adjustment, and calculates your readmission or mortality performance rate while accounting for the severity of your patient's illness when entering your facility.
The file you submit is a QRDA I file (like your eCQM submissions) but contains two things for each patient.
Core Clinical Data Elements (CCDEs) are patient data points like vital signs (heart rate, weight, oxygen saturation) and lab results (white blood cell count, glucose). These CCDEs reflect the clinical status when the patient first enters the hospital for treatment. They should be routinely and consistently captured in your EHR already, but you may need to update some clinical processes to make sure of that.
CMS needs a way to link those clinical elements with the patient information, so also included in the QRDA I file submission are Linking Variables.
Linking Variables are the same for each measure. All variables need to align 100% between the patient encounter (claims data), and the CCDEs in the file to count.
Linking variables included in the file submission:
As you review the required CCDEs for each measure, consider the timing graphic below. These measures will capture the earliest instance (<<that's key) of CCDE documentation meeting the timing requirements here. It is very specific and critical to the measure performance which is why we've highlighted this in the graphic below.
This measure is based on a patient unplanned readmission with 30-days of an inpatient admission and CMS will consider differences in case mix and service mix across all hospitals to come up with a final hybrid risk-standardized readmission rate.
There are 13 CCDEs captured for the hybrid HWR measure.
Vital Signs:
|
Lab Test Results:
|
In the measure specification, there is only an Initial Patient Population (IPP) and Denominator. There are no Exclusions, Exceptions or Numerator populations. Remember this is the clinical file which is combined with the claims file. CMS will calculate your score after submission.
IPP/Denominator
This measure is based on patient mortalities within 30-days of an inpatient encounter and CMS will consider differences in case mix and service mix across all hospitals to come up with a final hybrid risk-standardized mortality rate.
For the HWM measure, there are 10 CCDEs. Please note the addition of platelets to the lab test results CCDE. You'll want to ensure you've got that mapped to the appropriate LOINC code before starting.
Vital Signs:
|
Lab Test Results:
|
Just like the hybrid readmission measure, this measure specification has only an IPP and Denominator. Unlike the hybrid readmission measure, the mortality measure has an age range of 65 - 94 years.
IPP/Denominator
To meet the measure requirements, you must include the following, or it will not be accepted.
If you would like to learn more about the implementation of the hybrid measures, you can watch our on-demand webinar Prepping for Hybrid Measure Submissions. Resident eCQM expert, Kristen Beatson, reviews both measures in depth.
Medisolv Can HelpAlong with award-winning software, each client receives a dedicated Clinical Quality Advisor that helps you with your technical and clinical needs. We consistently hear from our clients that the biggest differentiator between Medisolv and other vendors is the level of one-of-one support. Especially if you use an EHR vendor right now, you’ll notice a huge difference.
|